Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 61936 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 69393 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 71303 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 82065 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 98541 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 99126 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 106615 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 168949 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 171869 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 197269 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 263653 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 265993 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 273936 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 303154 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 314364 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 328239 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | 331657 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | MYO-INOSITOL (CAS# 87-89-8); (M+NA)+ | Peak area | Severe disease |